Toscana Energy Reports Voting Results of Extraordinary Meeting of Debentureholders
Apr 23, 2018 23:11 pm UTC| Business
CALGARY, Alberta, April 23, 2018 -- Toscana Energy Income Corporation ("Toscana Energy" or the "Company") (TSX:TEI) held its extraordinary meeting (the "Meeting") of holders ("Debentureholders") of 6.75% convertible...
Apr 23, 2018 22:59 pm UTC| Business
SAN JOSE, Calif., April 23, 2018 -- On April 5, 2018, the law firm of Finkelstein Thompson LLP, filed a class action lawsuit against Facebook, Inc. and Cambridge Analytica. The lawsuit, Labajo v. Facebook, Inc. et al.,...
Immuron CEO to Present at RedChip Global Online Growth Conference
Apr 23, 2018 22:57 pm UTC| Business
MELBOURNE, Australia, April 23, 2018 -- Immuron Limited (ASX:IMC) (NASDAQ:IMRN), Australian microbiome biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies...
Apr 23, 2018 22:54 pm UTC| Business
HOUSTON, April 23, 2018 -- Vantage Drilling International (“Vantage” or the “Company”) announced today that it will host a conference call at 10:00 AM Eastern Time scheduled for May 4, 2018 to discuss operating results...
QC Holdings, Inc. Reports Fourth Quarter 2017 Results
Apr 23, 2018 22:30 pm UTC| Business
OVERLAND PARK, Kan., April 23, 2018 -- QC Holdings, Inc. (OTC PINK:QCCO) reported a net loss of $3.5 million and revenues of $98.2 million for the year ended December 31, 2017. Net loss totaled $16.8 million and...
Insight Enterprises, Inc. to Report First Quarter 2018 Financial Results on May 2, 2018
Apr 23, 2018 22:30 pm UTC| Business
TEMPE, Ariz., April 23, 2018 -- Insight Enterprises, Inc. (Nasdaq:NSIT) (the “Company”) today announced that it will release financial results for the quarter ended March 31, 2018 following the close of the market on...
Apellis Pharmaceuticals Announces Closing of Offering of Common Stock
Apr 23, 2018 22:21 pm UTC| Business
CRESTWOOD, Ky. and WALTHAM, Mass., April 23, 2018 -- Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease...